Variable | Unadjusted | Age-adjusted, sex-adjusted, serum IgG4 level-adjusted | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Age (per year) | 1.007 | 0.939 to 1.080 | 0.844 | 1.023 | 0.948 to 1.104 | 0.553 |
Male sex | 0.889 | 0.138 to 5.723 | 0.901 | 2.045 | 0.228 to 18.311 | 0.522 |
Allergy | 0.400 | 0.068 to 2.337 | 0.309 | 0.327 | 0.040 to 2.674 | 0.297 |
Serum IgG4 concentration at baseline (per 10Â mg/dL) | 0.988 | 0.970 to 1.005 | 0.175 | 0.983 | 0.963 to 1.005 | 0.125 |
Serum IgG concentration at baseline (per 10Â mg/dL) | 1.000 | 0.993 to 1.006 | 0.938 | 1.006 | 0.995 to 1.017 | 0.270 |
Serum IgE concentration at baseline (per 10Â IU/mL) | 1.056 | 1.004 to 1.111 | 0.035 | 1.090 | 1.013 to 1.174 | 0.022 |
Serum C3 concentration at baseline (per mg/dL) | 1.001 | 0.977 to 1.025 | 0.957 | 0.995 | 0.967 to 1.024 | 0.718 |
Serum C4 concentration at baseline (per mg/dL) | 0.987 | 0.896 to 1.088 | 0.795 | 0.982 | 0.881 to 1.094 | 0.740 |
Serum CH50 titer at baseline (per IU/L) | 0.987 | 0.940 to 1.036 | 0.585 | 0.980 | 0.928 to 1.034 | 0.452 |
Serum CRP concentration at baseline (per mg/dL) | 2.776 | 0.208 to 37.079 | 0.440 | 6.149 | 0.273 to 138.380 | 0.253 |
eGFR at baseline (per 10Â mL/min/1.73Â m2) | 0.600 | 0.365 to 0.987 | 0.043 | 0.520 | 0.273 to 0.993 | 0.048 |
Number of organs involved | 0.715 | 0.634 to 1.436 | 0.350 | 0.793 | 0.330 to 1.910 | 0.606 |
Initial PSL dose (per mg/kg/day) | 0.022 | 0.000 to 6.131 | 0.184 | 0.050 | 0.000 to 54.982 | 0.402 |
Other immunosuppressant drugs | 0.200 | 0.019 to 2.162 | 0.185 | 0.140 | 0.010 to 2.041 | 0.150 |
ARB | 1.875 | 0.250 to 14.082 | 0.541 | 1.008 | 0.088 to 11.573 | 0.995 |
Diabetes mellitus | 1.714 | 0.285 to 10.383 | 0.556 | 1.813 | 0.191 to 17.236 | 0.605 |
Hypertension | 1.875 | 0.250 to 14.082 | 0.541 | 0.908 | 0.070 to 11.815 | 0.941 |
Smoking habit | 0.833 | 0.150 to 4.636 | 0.835 | 0.652 | 0.091 to 4.655 | 0.669 |